º¸°ÇŸÀÓÁî
HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2023³â 10¿ù 01ÀÏ ÀÏ¿äÀÏ
·Î±×ÀÎÀÌ ÇÊ¿äÇÑ ¼­ºñ½ºÀÔ´Ï´Ù. ·Î±×ÀÎ ÇØÁÖ¼¼¿ä.
BKT´º½º ȸ¿øÀÌ ¾Æ´Ï½Å ºÐÀº ȸ¿ø°¡ÀÔÀ» ÇÏ½Ã¸é Æí¸®ÇÏ°Ô ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
ÀÚµ¿·Î±×ÀÎ
ȸ¿ø°¡ÀÔ ¾ÆÀ̵ð/ºñ¹Ð¹øÈ£Ã£±â
ÀÚ·á) °¢ ÀÇ·á±â°ü 2023³â ºñ±Þ¿© Áø·áºñ¿ë Á¶»çÀÚ·á 2023-09-20
³í¹®) Triplet maintenance therapy of olaparib... 2023-09-18
³í¹®) Clinical Outcome of Patients with Poor-Grade... 2023-09-15
³í¹®) MYC is a clinically significant driver of ..... 2023-09-14
ÀÚ·á) ºñ¸¸´ë»ç»ç¼úÀÇ ±Þ¿©È­ ÈÄ ¼ö¼ú ÇöȲ°ú ¼ö¼ú ÈÄ... 2023-09-13
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶
Copyright(c) 2007 BKTIMES.NET All rights Reserved.